{"id":"NCT01829295","sponsor":"University of California, San Francisco","briefTitle":"Methotrexate and Mycophenolate Mofetil for UVEITIS","officialTitle":"First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08","primaryCompletion":"2018-02-21","completion":"2018-08-09","firstPosted":"2013-04-11","resultsPosted":"2019-04-26","lastUpdate":"2024-04-02"},"enrollment":216,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Uveitis"],"interventions":[{"type":"DRUG","name":"Mycophenolate mofetil","otherNames":["Cellcept"]},{"type":"DRUG","name":"Methotrexate","otherNames":[]},{"type":"DRUG","name":"Prednisone","otherNames":[]}],"arms":[{"label":"Methotrexate","type":"EXPERIMENTAL"},{"label":"Mycophenolate Mofetil","type":"EXPERIMENTAL"}],"summary":"In the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial, the investigators propose to establish which immunosuppressive therapy, methotrexate or mycophenolate mofetil, is more effective as a first-line, corticosteroid-sparing agent for the treatment of non-infectious uveitis in a block-randomized, observer-masked, comparative effectiveness trial.","primaryOutcome":{"measure":"Number of Participants Achieving Treatment Success at 6 Months (Phase I, 0-6 Months)","timeFrame":"6 Months","effectByArm":[{"arm":"Methotrexate","deltaMin":64,"sd":null},{"arm":"Mycophenolate Mofetil","deltaMin":56,"sd":null}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":null},"locations":{"siteCount":9,"countries":["United States","Australia","India","Mexico","Saudi Arabia"]},"refs":{"pmids":["18579209","16163494","18455143","16061096","9951492","12750115","16808677","11262666","9917790","15693100","19748676","1483126","1407973","19344827","20042178","18221998","16196117","11024423","37294447","36749914","36701644","35143800","33675850","32779952","31503307","35085661","39190826"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":107},"commonTop":["Other systemic (no treatment required)","Fatigue","Headache","Nausea","Mood changes"]}}